PTEN Expression Contributes to the Regulation of Muscle Protein Degradation in Diabetes
Open Access
- 1 October 2007
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 56 (10), 2449-2456
- https://doi.org/10.2337/db06-1731
Abstract
OBJECTIVE—Conditions accelerating muscle proteolysis are frequently associated with defective phosphatidylinositol 3-kinase (PI3K)/Akt signaling and reduced PI3K-generated phosphatidylinositol 3,4,5-triphosphate (PIP3). We evaluated the control of muscle protein synthesis and degradation in mouse models of type 1 and 2 diabetes to determine whether defects besides PI3K/Akt activities affect muscle metabolism. RESEARCH DESIGN AND METHODS—We evaluated the expression and activity of PTEN, the phosphatase converting PIP3 to inactive phosphatidylinositol 4,5-bisphosphate, and studied how PTEN influences muscle protein in diabetic wild-type mice and in mice with partial deficiency of PTEN+/−. RESULTS—In acutely diabetic mice, muscle PTEN expression was decreased. It was increased by chronic diabetes or insulin resistance. In cultured C2C12 myotubes, acute suppression of PI3K activity led to decreased PTEN expression, while palmitic acid increased PTEN in myotubes in a p38-dependent fashion. To examine whether PTEN affects muscle protein turnover, we studied primary myotubes cultures from wild-type and PTEN+/− mice. The proteolysis induced by serum deprivation was suppressed in PTEN+/− cells. Moreover, the sizes of muscle fibers in PTEN+/− and wild-type mice were similar, but the increase in muscle proteolysis caused by acute diabetes was significantly suppressed by PTEN+/−. This antiproteolytic response involved higher PIP3 and p-Akt levels and a decrease in caspase-3–mediated actin cleavage and activation of the ubiquitin-proteasome system as signified by reduced induction of atrogin-1/MAFbx or MurF1 (muscle-specific RING finger protein 1). CONCLUSIONS—Changes in PTEN expression participate in the regulation of muscle proteolytic pathways. A decrease in PTEN could be a compensatory mechanism to prevent muscle protein losses.Keywords
This publication has 36 references indexed in Scilit:
- Development of a Diagnostic Method for Detecting Increased Muscle Protein Degradation in Patients with Catabolic ConditionsJournal of the American Society of Nephrology, 2006
- Regulation of the PTEN phosphataseGene, 2006
- Essential Role of Pten in Body Size Determination and Pancreatic β-Cell Homeostasis In VivoMolecular and Cellular Biology, 2006
- Chronic Kidney Disease Causes Defects in Signaling through the Insulin Receptor Substrate/Phosphatidylinositol 3-Kinase/Akt PathwayJournal of the American Society of Nephrology, 2006
- Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 2006
- Increase of PTEN Gene Expression in Insulin ResistanceHormone and Metabolic Research, 2004
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- Signalling pathways that mediate skeletal muscle hypertrophy and atrophyNature, 2003
- Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.The Journal of cell biology, 1994
- Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.JCI Insight, 1987